| 1 |
34983356 | Metainflammation in COVID-19. | 2022 Jan 4 |
1 |
| 2 |
35370738 | Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin. | 2022 |
1 |
| 3 |
33815295 | The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review. | 2021 |
1 |
| 4 |
34057870 | Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance. | 2021 Jun |
1 |
| 5 |
34646263 | Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis. | 2021 |
1 |
| 6 |
34664036 | A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19. | 2021 Dec |
1 |
| 7 |
34966196 | Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection. | 2021 |
1 |
| 8 |
34972763 | Association of the patterns of use of medications with mortality of COVID-19 infection: a hospital-based observational study. | 2021 Dec 31 |
2 |
| 9 |
32685191 | The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms. | 2020 |
1 |
| 10 |
32818905 | ACE2, Metformin, and COVID-19. | 2020 Jul 31 |
2 |
| 11 |
32838195 | Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection. | 2020 |
1 |
| 12 |
33081905 | [Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?] | 2020 Sep |
2 |
| 13 |
33471718 | Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19. | 2020 Oct |
1 |